Next 10 |
home / stock / rna / rna articles
These mid-cap stocks were the best performers in the last week. Are they in your portfolio? Avidity Biosciences, Inc. (NASDAQ:RNA) shares jumped 5...
With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows: Adobe Inc. (NA...
Avidity Biosciences (NASDAQ: RNA) announced encouraging initial data from the phase I/II FORTITUDE study evaluating two doses of delpacibart braxlo...
Shares of Streamline Health Solutions, Inc. (NASDAQ:STRM) fell sharply during Wednesday's session after the company reported worse-than-expect...
Avidity Biosciences (NASDAQ:RNA) stock is moving higher Wednesday following the company’s announcement that the Phase 1/2 FORTITUDE trial yie...
U.S. stocks were higher, with the Nasdaq Composite gaining over 250 points on Wednesday. Shares of Casey’s General Stores, Inc. (NASDAQ:CASY)...
Cantor Fitzgerald has initiated coverage on Avidity Biosciences Inc (NASDAQ:RNA), noting the company has the complete package, inclu...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quar...
News, Short Squeeze, Breakout and More Instantly...
Avidity Biosciences Inc. Company Name:
RNA Stock Symbol:
NASDAQ Market:
Avidity Biosciences Inc. Website:
Avidity Biosciences, Inc. (NASDAQ: RNA) is the focus of IBN's latest stock spotlight. The company's shares have moved 0.68% on the day to $40.18. Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonuc...
2024-06-24 08:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Avidity Biosciences Partners with the FSHD Society to Raise Awareness of Facioscapulohumeral Muscular Dystrophy on World FSHD Day PR Newswire FSHD Society to host Avidity webinar on positive initial data from the Phase 1/2 FORTITUDE™ trial for people living with FS...